Actively Recruiting

Phase Not Applicable
Age: 18Years - 85Years
All Genders
ID06883175

Evolution of the Chicago Classification: Bridging Physiology and Mechanics for Esophageal Disorders

Led by Northwestern University · Updated on 2025-08-11

575

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

N

Northwestern University

Lead Sponsor

T

The California Medical Innovations Institute, Inc.

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are studying swallowing difficulties, including functional dysphagia, ineffective esophageal motility (IEM), esophagogastric junction outflow obstruction (EGJOO), and achalasia. The trial aims to improve understanding of esophageal wall biomechanics and neuromyogenic function, which are important for normal swallowing but have been underexplored. This research builds on prior work that developed the Chicago Classification to diagnose esophageal motor disorders and seeks to identify new biomechanical markers for better diagnosis and treatment. The study uses advanced diagnostic tests like functional lumen impedance planimetry (FLIP), high-resolution manometry (HRM), and fluoroscopy-based techniques to measure esophageal wall mechanics, pressure, and diameter changes. Participants receive standard care and may undergo treatments such as prucalopride medication or botulinum toxin injections depending on their condition. The research includes assessments before and after interventions like peroral endoscopic myotomy (POEM) and fundoplication surgery to evaluate treatment effects. Participants aged 18 to 85 with swallowing issues or related esophageal conditions will complete questionnaires, imaging, endoscopy, and physiological tests at baseline and follow-up visits up to six months. Researchers will measure outcomes such as esophageal clearance, esophagogastric junction diameter and distensibility, reflux symptoms, and esophageal elasticity. These evaluations will help refine diagnostic models and treatment approaches for esophageal motility disorders.

CONDITIONS

Brief Title

Evolution of the Chicago Classification: Bridging Physiology and Mechanics

Who Can Participate

Age: 18Years - 85Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female aged 18 to 85 years old inclusive
  • Females of childbearing potential must use highly effective contraception
  • Mentally capable of providing informed consent
  • Presenting with dysphagia, regurgitation, chest pain, food impaction, or referred for treatment of achalasia, GERD, scleroderma, or endoscopy negative dysphagia
  • Able to undergo endoscopy with functional lumen imaging probe (FLIP), 4-dimensional high resolution manometry (4D HRM), and 24-hour pH impedance probe
Not Eligible

You will not qualify if you...

  • Currently participating in another clinical trial or completed one within the past 8 weeks
  • Active severe esophagitis (Grade C or above) unless healed but dysphagia persists
  • Mechanical obstruction due to stricture or previous small bowel or colonic obstruction
  • Long-segment Barrett's metaplasia
  • Unstable medical illness with ongoing treatment (well-controlled hypertension, diabetes, and stable ischemic heart disease allowed)
  • Current drug or alcohol abuse or dependency
  • Neurologic or cognitive impairment making research participation unsuitable
  • Severe mental illness such as uncontrolled major depression with suicidal ideation, active psychosis, or schizophrenia-spectrum disorder
  • Pregnant patients
  • Bleeding disorders or need for anticoagulation that cannot be stopped for endoscopy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Baseline assessments prior to treatment

Participants undergo standard of care diagnostic testing including endoscopy with FLIP, high resolution manometry (HRM), pH-impedance testing, and questionnaires to assess esophageal function and symptoms.

1 to 2 visits depending on procedures required

Treatment

Duration - 2 weeks for medication or as per clinical treatment schedule for POEM

Participants with specific esophageal conditions receive targeted treatments such as a 2-week course of prucalopride medication or undergo peroral endoscopic myotomy (POEM) as part of their clinical care.

1 to 2 treatment visits plus medication daily as prescribed

Post-treatment Diagnostic Evaluation

Duration - Up to 6 months after treatment

After treatment, participants undergo follow-up diagnostic procedures including FLIP, HRM, esophagram evaluation, and questionnaires to assess treatment effects.

1 to 2 visits up to 6 months post-treatment

Long-term Monitoring

Duration - Up to 6 months post-treatment

Participants are monitored over time to assess long-term outcomes such as esophageal clearance, symptom improvement, and treatment success.

Follow-up visits over 6 months

Trial Site Locations

Total: 1 location

1

Northwestern University

Chicago, Illinois, United States, 60611

Actively Recruiting

Loading map...

Research Team

J

John E Pandolfino, MD

D

Dustin A Carlson, MD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Similar Trials

Adaptive RadioTherapy for Locally Advanced OroPharynx Cancer...

Oropharynx Cancer

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Assessing bolus retention in achalasia using high-resolution manometry with impedance: a comparator study with timed barium esophagram.

Yu K Cho, Anna M Lipowska, Frédéric Nicodème...

https://pubmed.ncbi.nlm.nih.gov/24710506

Correlation between the radiological observation of isolated tertiary waves on an esophagram and findings on high-resolution esophageal manometry.

M Halland, K Ravi, J Barlow...

https://pubmed.ncbi.nlm.nih.gov/25327483

Development of the Northwestern Esophageal Quality of Life Scale: A Hybrid Measure for Use Across Esophageal Conditions.

Alyse Bedell, Tiffany H Taft, Laurie Keefer...

https://pubmed.ncbi.nlm.nih.gov/26881974

t-Distributed Stochastic Neighbor Embedding (t-SNE): A tool for eco-physiological transcriptomic analysis.

Matthew C Cieslak, Ann M Castelfranco, Vittoria Roncalli...

https://pubmed.ncbi.nlm.nih.gov/31784353

Esophagogastric junction distensibility measurements during Heller myotomy and POEM for achalasia predict postoperative symptomatic outcomes.

Ezra N Teitelbaum, Nathaniel J Soper, John E Pandolfino...

https://pubmed.ncbi.nlm.nih.gov/25055891